Arthralgias and Myalgias Related to Quinupristin-Dalfopristin Administration

This study evaluated the frequency of and potential risk factors for arthralgias and/or myalgias associated with quinupristin-dalfopristin administration. Of 32 patients who received quinupristin-dalfopristin treatment, at least 15 (47%) developed arthralgias and/or myalgias. Clinicians should be aw...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2001-02, Vol.32 (4), p.e83-e86
Main Authors: Olsen, Keith M., Rebuck, Jill A., Rupp, Mark E.
Format: Article
Language:English
Subjects:
Arthralgia - chemically induced
Arthralgia - diagnosis
Drug Therapy, Combination - adverse effects
Gram-Positive Bacterial Infections - drug therapy
Humans
Muscular Diseases - chemically induced
Muscular Diseases - diagnosis
Pain - chemically induced
Retrospective Studies
Risk Factors
Virginiamycin - adverse effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study evaluated the frequency of and potential risk factors for arthralgias and/or myalgias associated with quinupristin-dalfopristin administration. Of 32 patients who received quinupristin-dalfopristin treatment, at least 15 (47%) developed arthralgias and/or myalgias. Clinicians should be aware of these adverse events associated with quinupristin-dalfopristin, which may occur more frequently than has been previously reported.
ISSN:1058-4838
1537-6591
DOI:10.1086/318702